Intrinsiqq
Bespoke Extracts Inc. logo

Bespoke Extracts Inc. Insider Trading

BSPK

⊜ Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Sep 2025.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Sep 2025
Sep 11, 2025

Get an email when BSPK's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 10, 2025 – Sep 11, 2025
    Michael Feinsod
    CEO · bought 3,500 at avg $0.22
    $785
    0.1% of stake
  • Sep 8, 2025
    Michael Feinsod
    CEO · bought 2,500 at $0.19
    $475
    <0.1% of stake
  • Sep 5, 2025
    Michael Feinsod
    CEO · bought 2,500 at $0.20
    $500
    <0.1% of stake
  • Jul 2, 2025
    Michael Feinsod
    CEO · bought 8,000 at $0.11
    $880
    0.3% of stake
  • May 9, 2025 – May 12, 2025
    Michael Feinsod
    CEO · bought 2,000 at avg $0.11
    $210
    <0.1% of stake
  • Jan 30, 2025 – Jan 31, 2025
    Michael Feinsod
    CEO · bought 3,000 at avg $0.11
    $330
    0.1% of stake
  • Jan 22, 2025 – Jan 23, 2025
    Michael Feinsod
    CEO · bought 8,000 at avg $0.11
    $845
    0.3% of stake
  • Jan 2, 2025 – Jan 3, 2025
    Michael Feinsod
    CEO · bought 13,000 at avg $0.11
    1K
    0.5% of stake
  • Nov 12, 2024 – Nov 14, 2024
    Michael Feinsod
    CEO · bought 4,000 at avg $0.17
    $685
    0.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BSPK, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BSPK

CompareIntrinsic value
CATXPerspective Therapeutics Inc.
$0.87-1.11%10
ATXIAvenue Therapeutics Inc.
$0.40+0.00%10
HYPDHyperion DeFi, Inc.
$3.23+5.74%25
RNACCartesian Therapeutics Inc.
$6.84+6.71%10
DAREDare Bioscience Inc.
$0.66+1.83%10
LPCNLipocine Inc.
$1.44-1.37%40
OVIDOvid Therapeutics Inc.
$2.74+14.17%25
LGVNLongeveron Inc.
$1.78+0.00%10

Spot a number that looks wrong? Check it in BSPK's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BSPK

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.